BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11768238)

  • 1. Distribution of Fhit protein in rat tissues and its intracellular localization.
    Golebiowski F; Kowara R; Pawelczyk T
    Mol Cell Biochem; 2001 Oct; 226(1-2):49-55. PubMed ID: 11768238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Fhit tumor suppressor protein regulates the intracellular concentration of diadenosine triphosphate but not diadenosine tetraphosphate.
    Murphy GA; Halliday D; McLennan AG
    Cancer Res; 2000 May; 60(9):2342-4. PubMed ID: 10811104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the fragile histidine triad gene in normal rat tissues and human kidney cancer cell lines.
    Lee SH; Kim TJ; Kim HY; Kim JG; Park MK; Woo KM; Kim SH; Hwang KY; Nam HS; Min YK; Cho MH
    Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):145-57. PubMed ID: 15080505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase.
    Barnes LD; Garrison PN; Siprashvili Z; Guranowski A; Robinson AK; Ingram SW; Croce CM; Ohta M; Huebner K
    Biochemistry; 1996 Sep; 35(36):11529-35. PubMed ID: 8794732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering human Fhit, a diadenosine triphosphate hydrolase, into an efficient dinucleoside polyphosphate synthase.
    Huang K; Frey PA
    J Am Chem Soc; 2004 Aug; 126(31):9548-9. PubMed ID: 15291552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubc9-induced inhibition of diadenosine triphosphate hydrolase activity of the putative tumor suppressor protein Fhit.
    Golebiowski F; Szulc A; Szutowicz A; Pawelczyk T
    Arch Biochem Biophys; 2004 Aug; 428(2):160-4. PubMed ID: 15246872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of 5',5'-dinucleoside triphosphate catabolism by APH1, a Saccharomyces cerevisiae analog of human FHIT.
    Chen J; Brevet A; Blanquet S; Plateau P
    J Bacteriol; 1998 May; 180(9):2345-9. PubMed ID: 9573184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and simple, one-step purification of fragile histidine triad (Fhit) tumor suppressor mutant forms in Escherichia coli and their interaction with protoporphyrin IX.
    Zawacka-Pankau J; Podhajska AJ
    Biotechnol Lett; 2007 Jun; 29(6):877-83. PubMed ID: 17310323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replacement of Fhit in cancer cells suppresses tumorigenicity.
    Siprashvili Z; Sozzi G; Barnes LD; McCue P; Robinson AK; Eryomin V; Sard L; Tagliabue E; Greco A; Fusetti L; Schwartz G; Pierotti MA; Croce CM; Huebner K
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13771-6. PubMed ID: 9391102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fhit protein is preferentially expressed in the nucleus of monocyte-derived cells and its possible biological significance.
    Zhao P; Hou N; Lu Y
    Histol Histopathol; 2006 Sep; 21(9):915-23. PubMed ID: 16763940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two hydrolase resistant analogues of diadenosine 5',5"'-P1,P3-triphosphate for studies with Fhit, the human fragile histidine triad protein.
    Blackburn GM; Liu X; Rösler A; Brenner C
    Nucleosides Nucleotides; 1998; 17(1-3):301-8. PubMed ID: 9708352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased fragile histidine triad gene messenger RNA expression in lung cancer.
    Sasaki H; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Clin Lung Cancer; 2006 May; 7(6):412-6. PubMed ID: 16800968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning of the canine fragile histidine triad (FHIT) gene and Fhit protein expression in canine peripheral blood mononuclear cells.
    Hiraoka H; Minami K; Kaneko N; Shimokawa Miyama T; Mizuno T; Okuda M
    J Vet Med Sci; 2009 May; 71(5):645-9. PubMed ID: 19498293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of intracellular diadenosine triphosphate (Ap3A) with apoptosis in Fhit-positive HEK293 cells.
    Fisher DI; McLennan AG
    Cancer Lett; 2008 Feb; 259(2):186-91. PubMed ID: 18006149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and immunochemical characterisation of human diadenosine triphosphatase provides evidence for its identification with the tumour suppressor Fhit protein.
    Asensio AC; Rodríguez-Ferrer CR; Oaknin S; Rotllán P
    Biochimie; 2006 May; 88(5):461-71. PubMed ID: 16359767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragile histidine triad (FHIT) gene is overexpressed in colorectal cancer.
    Wierzbicki PM; Adrych K; Kartanowicz D; Dobrowolski S; Stanislawowski M; Chybicki J; Godlewski J; Korybalski B; Smoczynski M; Kmiec Z
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():63-70. PubMed ID: 20083853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [FHIT--tumor suppressor protein involved in induction of apoptosis and cell cycle regulation].
    Pecherzewska R; Nawrot B
    Postepy Biochem; 2009; 55(1):66-75. PubMed ID: 19514467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical Proteomics of the Tumor Suppressor Fhit Covalently Bound to the Cofactor Ap
    Herzog D; Jansen J; Mißun M; Diederichs K; Stengel F; Marx A
    J Am Chem Soc; 2022 May; 144(19):8613-8623. PubMed ID: 35522782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of FHIT transcripts in normal and malignant breast tissue.
    Bièche I; Latil A; Becette V; Lidereau R
    Genes Chromosomes Cancer; 1998 Dec; 23(4):292-9. PubMed ID: 9824201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic, biochemical, and crystallographic characterization of Fhit-substrate complexes as the active signaling form of Fhit.
    Pace HC; Garrison PN; Robinson AK; Barnes LD; Draganescu A; Rösler A; Blackburn GM; Siprashvili Z; Croce CM; Huebner K; Brenner C
    Proc Natl Acad Sci U S A; 1998 May; 95(10):5484-9. PubMed ID: 9576908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.